Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Dosing begins in phase I study of BBP-418 for limb girdle muscular dystrophy type 2i

June 11, 2020

Phase III trial of INP-104 for acute migraine meets primary objectives

June 11, 2020

Roche synthesizes new MGL inhibitors

June 11, 2020

Nuclear quality control by chaperones

June 11, 2020

Stroke protection effects like night and day

June 9, 2020

Sleep deprivation kills through punch to the gut

June 8, 2020

Phase I study of hCT-MSC in neonates with hypoxic-ischemic encephalopathy

June 8, 2020

Molecular pair offers potential Parkinson's treatment

June 5, 2020

Selective TREK channel activator alleviates pain in mice without opioid-like adverse effects

June 5, 2020

IRLAB announces preparations for phase IIb/III study of mesdopetam in PD

June 5, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...